Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1955 1
1960 1
1961 1
1963 1
1965 1
1968 1
1971 2
1972 1
1975 2
1976 1
1977 1
1979 2
1980 3
1981 1
1982 4
1983 1
1985 2
1992 1
1993 2
1996 1
1999 1
2000 1
2001 1
2002 2
2004 4
2005 3
2007 1
2008 4
2009 3
2010 4
2011 3
2012 7
2013 9
2014 5
2015 7
2016 4
2017 7
2018 9
2019 7
2020 6
2021 6
2022 6
2023 13
2024 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

145 results

Results by year

Filters applied: . Clear all
Page 1
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.
Goldsmith KC, Park JR, Kayser K, Malvar J, Chi YY, Groshen SG, Villablanca JG, Krytska K, Lai LM, Acharya PT, Goodarzian F, Pawel B, Shimada H, Ghazarian S, States L, Marshall L, Chesler L, Granger M, Desai AV, Mody R, Morgenstern DA, Shusterman S, Macy ME, Pinto N, Schleiermacher G, Vo K, Thurm HC, Chen J, Liyanage M, Peltz G, Matthay KK, Berko ER, Maris JM, Marachelian A, Mossé YP. Goldsmith KC, et al. Among authors: granger m. Nat Med. 2023 May;29(5):1092-1102. doi: 10.1038/s41591-023-02297-5. Epub 2023 Apr 3. Nat Med. 2023. PMID: 37012551 Free PMC article. Clinical Trial.
Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321).
Dunkel IJ, Piao J, Chantada GL, Banerjee A, Abouelnaga S, Buchsbaum JC, Merchant TE, Granger MM, Jubran RF, Weinstein JL, Saguilig L, Abramson DH, Krailo MD, Rodriguez-Galindo C, Chintagumpala MM. Dunkel IJ, et al. Among authors: granger mm. J Clin Oncol. 2022 Nov 20;40(33):3839-3847. doi: 10.1200/JCO.21.02337. Epub 2022 Jul 12. J Clin Oncol. 2022. PMID: 35820112 Free PMC article. Clinical Trial.
Human Milk Bioactive Components and Child Growth and Body Composition in the First 2 Years: A Systematic Review.
Brockway MM, Daniel AI, Reyes SM, Gauglitz JM, Granger M, McDermid JM, Chan D, Refvik R, Sidhu KK, Musse S, Patel PP, Monnin C, Lotoski L, Geddes DT, Jehan F, Kolsteren P, Bode L, Eriksen KG, Allen LH, Hampel D, Rodriguez N, Azad MB. Brockway MM, et al. Among authors: granger m. Adv Nutr. 2024 Jan;15(1):100127. doi: 10.1016/j.advnut.2023.09.015. Epub 2023 Oct 4. Adv Nutr. 2024. PMID: 37802214 Free PMC article. Review.
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M; EURAMOS-1 investigators. Bielack SS, et al. J Clin Oncol. 2015 Jul 10;33(20):2279-87. doi: 10.1200/JCO.2014.60.0734. Epub 2015 Jun 1. J Clin Oncol. 2015. PMID: 26033801 Free PMC article. Clinical Trial.
Évaluation médico-économique des produits de santé. Méthodologie pour la définition d'un impact significatif sur les dépenses de l'Assurance maladie et choix des référentiels pour l'interprétation des résultats.
Dervaux B, Baseilhac E, Fagon JY; et les participants à la table ronde N°4 de Giens XXIX :; Biot C, Blachier C, Braun E, Debroucker F, Detournay B, Ferretti C, Granger M, Jouan-Flahault C, Lussier MD, Meyer A, Muller S, Pigeon M, De Sahb R, Sannié T, Sapède C, Vray M. Dervaux B, et al. Among authors: granger m. Therapie. 2014 Jul-Aug;69(4):323-30. doi: 10.2515/therapie/2014046. Therapie. 2014. PMID: 27393226 French. No abstract available.
Human Milk Macronutrients and Child Growth and Body Composition in the First Two Years: A Systematic Review.
Brockway MM, Daniel AI, Reyes SM, Granger M, McDermid JM, Chan D, Refvik R, Sidhu KK, Musse S, Patel PP, Monnin C, Lotoski L, Geddes D, Jehan F, Kolsteren P, Allen LH, Hampel D, Eriksen KG, Rodriguez N, Azad MB. Brockway MM, et al. Among authors: granger m. Adv Nutr. 2024 Jan;15(1):100149. doi: 10.1016/j.advnut.2023.100149. Epub 2023 Nov 18. Adv Nutr. 2024. PMID: 37981047 Free PMC article.
L'évaluation médico-économique des produits de santé dans le contexte de la loi de financement de la Sécurité sociale pour 2012.
Dervaux B, Baseilhac E, Fagon JY; les participants à la table ronde N°6 de Giens XXVIII :; Ameye V, Angot P, Audry A, Becquemont L, Borel T, Cazeneuve B, Courtois J, Detournay B, Favre P, Granger M, Josseran A, Lassale C, Louvet O, Pinson J, de Pouvourville G, Rochaix L, Rumeau-Pichon C, de Saab R, Schwarzinger M, Sun A. Dervaux B, et al. Among authors: granger m. Therapie. 2013 Jul-Aug;68(4):253-7. doi: 10.2515/therapie/2013044. Therapie. 2013. PMID: 27392727 French. No abstract available.
Dietary Vitamin C in Human Health.
Granger M, Eck P. Granger M, et al. Adv Food Nutr Res. 2018;83:281-310. doi: 10.1016/bs.afnr.2017.11.006. Epub 2018 Feb 16. Adv Food Nutr Res. 2018. PMID: 29477224 Review.
Telomerase in cancer and aging.
Granger MP, Wright WE, Shay JW. Granger MP, et al. Crit Rev Oncol Hematol. 2002 Jan;41(1):29-40. doi: 10.1016/s1040-8428(01)00188-3. Crit Rev Oncol Hematol. 2002. PMID: 11796230 Review.
145 results